Condition
Atrial Fibrillation, Postoperative
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06989775Not ApplicableRecruiting
BoxX-NoAF Clinical Trial
NCT06730828Phase 1RecruitingPrimary
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
NCT02783157Not ApplicableTerminatedPrimary
Transcutaneous Autonomic Modulation in Thoracic Surgery
NCT02145858Completed
Prevention of Retained-Blood Outcomes With Active Clearance Technology
Showing all 4 trials